VOGX

Vogenx Inc Common Stock

Price Chart

Latest Quote

$14.09

+1.09 (+8.38%)

Current Price

Previous Close	$13.00
Open	$13.09
Day High	$14.20
Day Low	$13.00
Volume	81,018

Fetched: 2026-08-14T06:16:23

Stock Information

Shares Outstanding	13.91M
Total Debt	$836K
Cash Equivalents	$251K
Net Income	$-1.56M
Sector	Healthcare
Industry	Biotechnology
Market Cap	$195.93M
EPS (TTM)	$-0.22
Exchange	NGM

🌐 Visit Website

📊 Comprehensive Analysis

Company Data

Enterprise Value	$74.74M
Income	$-1.56M
Book/sh	$-0.09
Cash/sh	$0.02
Employees	4

Financial Ratios

Quick Ratio	0.11
Current Ratio	0.39

Returns & Margins

Ownership

Insider & Institutional transactions data not available

Valuation Ratios

P/B

-158.31

Analyst Data

Recommendation

none

Technical Indicators

Performance History

YTD	+8.38%
10 Years	+8.38%

Stock Score: ⭐ Premium

Based on debt, profitability, growth, and cash flow metrics

⭐ Premium Feature

Recent Price History

Date	Close	Volume
2026-08-13	$14.09	81,000
2026-08-12	$13.00	684,000

About Vogenx Inc Common Stock

Vogenx, Inc. operates as a clinical-stage drug development company that develops therapeutics for metabolic including post-bariatric hypoglycemia, or PBH, and gastroparesis. Its products include drugs, such as Mizagliflozin and VGX-2857. It also offers VGX-001, a human monoclonal antibody for the treatment of type 1 diabetes (T1D). It caters to healthcare providers, physicians and third-party payors in the United States. The company was incorporated in 2021 and is based in Raleigh, North Carolina.

📰 Latest News

No news articles available at the moment. Check back later for updates on VOGX.

Period:

Income Statement (Annual)

Metric	2025-12-31	2024-12-31
Revenue
Total Revenue	$0	$0
Operating Revenue	$0	$0
Expenses
Total Expenses	$1,439,118	$2,300,834
Other Income Expense	$-12,516	$58,030
Other Non Operating Income Expenses	$-66,300	-
Net Non Operating Interest Income Expense	$6,031	$39,213
Operating Expense	$1,439,118	$2,300,834
General And Administrative Expense	$867,153	$984,309
Income & Earnings
Net Income From Continuing Operation Net Minority Interest	$-1,445,603	$-2,203,591
Net Interest Income	$6,031	$39,213
Interest Income	$6,031	$39,213
Normalized Income	$-1,499,387	$-2,261,621
Net Income From Continuing And Discontinued Operation	$-1,445,603	$-2,203,591
Net Income Common Stockholders	$-1,445,603	$-2,203,591
Net Income	$-1,445,603	$-2,203,591
Net Income Including Noncontrolling Interests	$-1,445,603	$-2,203,591
Net Income Continuous Operations	$-1,445,603	$-2,203,591
Pretax Income	$-1,445,603	$-2,203,591
Interest Income Non Operating	$6,031	$39,213
Operating Income	$-1,439,118	$-2,300,834
Other
Tax Effect Of Unusual Items	$0	$0
Tax Rate For Calcs	$0	$0
Normalized EBITDA (Bullshit earnings)	$-1,492,902	$-2,358,864
Total Unusual Items	$53,784	$58,030
Total Unusual Items Excluding Goodwill	$53,784	$58,030
EBITDA (Bullshit earnings)	$-1,439,118	$-2,300,834
EBIT	$-1,439,118	$-2,300,834
Diluted NI Availto Com Stockholders	$-1,445,603	$-2,203,591
Gain On Sale Of Security	$53,784	$58,030
Research And Development	$571,965	$1,316,525
Selling General And Administration	$867,153	$984,309
Other Gand A	$867,153	$984,309

Fetched: 2026-08-13

Balance Sheet (Annual)

Metric	2025-12-31	2024-12-31
Assets
Net Tangible Assets	$-919,235	$509,584
Total Assets	$681,170	$970,398
Total Non Current Assets	$0	$0
Current Assets	$681,170	$970,398
Current Deferred Assets	$63,363	-
Prepaid Assets	$16,797	$7,475
Cash Cash Equivalents And Short Term Investments	$601,010	$962,923
Cash And Cash Equivalents	$601,010	$962,923
Debt
Net Debt	$215,290	-
Total Debt	$816,300	-
Current Debt And Capital Lease Obligation	$816,300	-
Current Debt	$816,300	-
Other Current Borrowings	$816,300	-
Liabilities
Total Liabilities Net Minority Interest	$1,600,405	$460,814
Total Non Current Liabilities Net Minority Interest	$11,323	$65,107
Derivative Product Liabilities	$11,323	$65,107
Current Liabilities	$1,589,082	$395,707
Payables And Accrued Expenses	$486,282	$395,707
Payables	$486,282	$395,707
Other Payable	$363,318	$286,500
Accounts Payable	$62,964	$109,207
Equity
Common Stock Equity	$-919,801	$509,018
Preferred Stock Equity	$566	$566
Total Equity Gross Minority Interest	$-919,235	$509,584
Stockholders Equity	$-919,235	$509,584
Retained Earnings	$-10,841,670	$-9,396,067
Other
Tangible Book Value	$-919,801	$509,018
Invested Capital	$-103,501	$509,018
Working Capital	$-907,912	$574,691
Total Capitalization	$-919,235	$509,584
Additional Paid In Capital	$9,920,290	$9,903,506
Capital Stock	$2,145	$2,145
Common Stock	$1,579	$1,579
Preferred Stock	$566	$566
Pensionand Other Post Retirement Benefit Plans Current	$286,500	-
Dueto Related Parties Current	$60,000	-

Fetched: 2026-08-13

Cash Flow Statement (Annual)

Metric	2025-12-31	2024-12-31
Free Cash Flow
Free Cash Flow	$-1,111,913	$-2,341,372
Operating Activities
Operating Cash Flow	$-1,111,913	$-2,341,372
Cash Flow From Continuing Operating Activities	$-1,111,913	$-2,341,372
Operating Gains Losses	$-53,784	$-58,030
Financing Activities
Financing Cash Flow	$750,000	$0
Cash Flow From Continuing Financing Activities	$750,000	$0
Other
Issuance Of Debt	$750,000	$0
End Cash Position	$601,010	$962,923
Beginning Cash Position	$962,923	$3,304,295
Changes In Cash	$-361,913	$-2,341,372
Net Issuance Payments Of Debt	$750,000	$0
Net Short Term Debt Issuance	$750,000	$0
Short Term Debt Issuance	$750,000	$0
Change In Working Capital	$304,390	$-167,052
Change In Payables And Accrued Expense	$377,075	$-239,804
Change In Accrued Expense	$423,318	$-10,625
Change In Payable	$-46,243	$-229,179
Change In Account Payable	$-46,243	$-229,179
Change In Prepaid Assets	$-72,685	$72,752
Other Non Cash Items	$60,500	-
Stock Based Compensation	$16,784	$87,301
Unrealized Gain Loss On Investment Securities	$5,800	$0
Gain Loss On Investment Securities	$-53,784	$-58,030
Net Income From Continuing Operations	$-1,445,603	$-2,203,591

Fetched: 2026-08-13